Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Inside back cover
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
Long-term outcomes and valve durability
Background Early data for transcatheter aortic valve implantation (TAVI) was limited to inoperable and high surgical risk patients and as such the life span of the implanted prosthesis may be expected to exceed the life expectancy of these high-risk recipients.…
Antithrombotic therapy and recommended follow-up
Antithrombotic therapy after TAVI Prosthetic valves have known thromboembolic complications, especially in the short term, with an incidence observed to be <1% to almost 8% in the first year after transcatheter aortic valve implantation (TAVI). However, the prevention of these…
Arrhythmias and pacemaker implantation
Although most complications of transcatheter aortic valve implantation (TAVI) have decreased over time, the rate of arrhythmic complications and conduction abnormalities seems to remain stable. Indeed, the introduction of newer-generation devices has not resulted in a reduction of these complications,…
Transcatheter aortic valve implantation–related procedural and device complications
Since its introduction into clinical practice, transcatheter aortic valve implantation (TAVI) has proven to be a transformational technology, where the implantation of the new valve is done without the need for complex surgery, usually via the femoral artery under local…
Advanced indications for transcatheter valve implantation
Transcatheter aortic valve implantation (TAVI) may be performed for conditions that are outside the currently labeled indication of symptomatic severe stenosis of trileaflet aortic valve. TAVI in bicuspid aortic stenosis was excluded from the major commercial randomized controlled trials and…
Vascular closure
Introduction Over the past decade there have been huge advances in transfemoral (TF) transcatheter aortic valve implantation (TAVI), including changes to both the prosthesis and delivery systems. This evolution has resulted in lower profile delivery systems thus enabling TF TAVI…
Transcatheter aortic valve implantation: Procedural details
Introduction After the first-in-human transcatheter aortic valve implantation (TAVI) more than 15 years ago, this procedure continues to be developed and refined. This chapter aims to provide the reader with knowledge about TAVI implantation from finding the optimal coplanar view…
Cerebral protection
Introduction Aortic stenosis is the most common valvular heart disease in the geriatric age group. Transcatheter aortic valve implantation (TAVI) has become the standard of care and is superior to conventional surgery. The indication for TAVI has extended from prohibitive…
Sedation and anesthetic support
Conscious sedation The first-in-man transcatheter aortic valve implantation (TAVI) was performed percutaneously by a French team led by Alain Cribier under conscious sedation (CS). Despite this precedent, the majority of subsequent early TAVI cases were performed under general anesthesia (GA)…